title: Cerebral effects of carbamazepine capsules and Divitabs in psychiatric patients.
authors.forename: A J
authors.initials: AJ
authors.lastname: Loonen
authors.forename: C H
authors.initials: CH
authors.lastname: Doorschot
authors.forename: L P
authors.initials: LP
authors.lastname: Van Bavel
authors.forename: B
authors.initials: B
authors.lastname: Groot
authors.forename: H J
authors.initials: HJ
authors.lastname: De Blok
authors.forename: L J
authors.initials: LJ
authors.lastname: Krijgsman
authors.forename: P H
authors.initials: PH
authors.lastname: Van Dongen
authors.forename: A A
authors.initials: AA
authors.lastname: Jaspers
authors.forename: L C
authors.initials: LC
authors.lastname: Vanbrabant
mesh_terms: D000328:Adult; D001921:Brain / Q000187:drug effects*; D002214:Capsules; D002220:Carbamazepine / Q000008:administration & dosage / Q000009:adverse effects* / Q000493:pharmacokinetics; D003072:Cognition Disorders / Q000139:chemically induced* / Q000175:diagnosis; D003692:Delayed-Action Preparations; D003866:Depressive Disorder / Q000188:drug therapy; D004827:Epilepsy / Q000188:drug therapy; D005260:Female; D006801:Humans; D008297:Male; D008875:Middle Aged; D009483:Neuropsychological Tests
chemical_list: D002214:Capsules; D003692:Delayed-Action Preparations; D002220:Carbamazepine